Judith Jans

3.9k total citations
100 papers, 2.1k citations indexed

About

Judith Jans is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Judith Jans has authored 100 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 35 papers in Clinical Biochemistry and 25 papers in Physiology. Recurrent topics in Judith Jans's work include Metabolism and Genetic Disorders (35 papers), Metabolomics and Mass Spectrometry Studies (18 papers) and Erythrocyte Function and Pathophysiology (16 papers). Judith Jans is often cited by papers focused on Metabolism and Genetic Disorders (35 papers), Metabolomics and Mass Spectrometry Studies (18 papers) and Erythrocyte Function and Pathophysiology (16 papers). Judith Jans collaborates with scholars based in Netherlands, United States and United Kingdom. Judith Jans's co-authors include Nanda M. Verhoeven‐Duif, Peter M. van Hasselt, Monique G.M. de Sain–van der Velden, Hanneke A. Haijes, Hubertus C.M.T. Prinsen, Gijsbertus T. J. van der Horst, Maria van der Ham, Gepke Visser, Jan H.J. Hoeijmakers and Barbara J Meyer and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Judith Jans

97 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judith Jans Netherlands 27 1.3k 409 263 262 243 100 2.1k
David A. Stroud Australia 33 3.6k 2.8× 891 2.2× 535 2.0× 401 1.5× 229 0.9× 70 4.7k
Eri Kubo Japan 30 1.7k 1.4× 353 0.9× 147 0.6× 287 1.1× 88 0.4× 111 2.6k
Massimo Micaroni Italy 20 2.5k 2.0× 394 1.0× 274 1.0× 365 1.4× 105 0.4× 27 3.3k
Gerd Birkenmeier Germany 27 1.2k 1.0× 111 0.3× 292 1.1× 322 1.2× 119 0.5× 92 2.3k
Sara Violante United States 17 1.4k 1.1× 318 0.8× 409 1.6× 416 1.6× 146 0.6× 29 2.3k
Candace Guerrero United States 12 2.1k 1.7× 70 0.2× 296 1.1× 174 0.7× 77 0.3× 21 2.8k
Giovanna Angelini Italy 27 847 0.7× 185 0.5× 189 0.7× 522 2.0× 481 2.0× 57 2.9k
Atsushi Hashimoto Japan 24 866 0.7× 70 0.2× 79 0.3× 213 0.8× 96 0.4× 73 2.0k
Katalin Bánki United States 30 1.1k 0.9× 85 0.2× 150 0.6× 227 0.9× 199 0.8× 50 2.9k
Ulrich Warskulat Germany 34 1.1k 0.8× 144 0.4× 143 0.5× 622 2.4× 66 0.3× 67 3.1k

Countries citing papers authored by Judith Jans

Since Specialization
Citations

This map shows the geographic impact of Judith Jans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Jans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Jans more than expected).

Fields of papers citing papers by Judith Jans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Jans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Jans. The network helps show where Judith Jans may publish in the future.

Co-authorship network of co-authors of Judith Jans

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Jans. A scholar is included among the top collaborators of Judith Jans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Jans. Judith Jans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oirschot, Brigitte A. van, Judith Jans, Megan Wind‐Rotolo, et al.. (2025). Ex vivo activation of pyruvate kinase improves red blood cell metabolism and hydration in hereditary spherocytosis. 1(1). 100005–100005.
2.
Levine, Charles, Anita W. Rijneveld, Judith Jans, et al.. (2025). Red blood cell pyruvate kinase properties in Townes and Berkeley sickle cell disease mouse models – Of mice and men. Blood Cells Molecules and Diseases. 111. 102909–102909.
3.
Karnebeek, Clara D.M. van, Anne O’Donnell‐Luria, Gareth Baynam, et al.. (2024). Leaving no patient behind! Expert recommendation in the use of innovative technologies for diagnosing rare diseases. Orphanet Journal of Rare Diseases. 19(1). 357–357. 7 indexed citations
4.
Schene, Imre F., Marisa I. Mendes, Desirée E.C. Smith, et al.. (2024). Isoleucine-to-valine substitutions support cellular physiology during isoleucine deprivation. Nucleic Acids Research. 53(1). 1 indexed citations
5.
Jansen, M., Amand F. Schmidt, Judith Jans, et al.. (2023). Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers. Journal of Cardiovascular Translational Research. 16(6). 1267–1275. 4 indexed citations
6.
Jans, Judith, Vassiliki Konstantopoulou, René G. Feichtinger, et al.. (2023). PPA1 Deficiency Causes a Deranged Galactose Metabolism Recognizable in Neonatal Screening. Metabolites. 13(11). 1141–1141. 1 indexed citations
7.
Jansen, M., Maike Schuldt, Amand F. Schmidt, et al.. (2023). Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants. International Journal of Molecular Sciences. 24(4). 4031–4031. 9 indexed citations
8.
Rab, Minke A.E., Brigitte A. van Oirschot, Anita W. Rijneveld, et al.. (2023). One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study. Blood Advances. 7(24). 7539–7550. 8 indexed citations
9.
Albada, Mirjam E. van, Pratik Shah, Terry G. J. Derks, et al.. (2023). Abnormal glucose homeostasis and fasting intolerance in patients with congenital porto-systemic shunts. Frontiers in Endocrinology. 14. 1190473–1190473. 2 indexed citations
10.
Willemen, Hanneke L.D.M., Sabine Versteeg, Teun P. de Boer, et al.. (2023). Inflammation-induced mitochondrial and metabolic disturbances in sensory neurons control the switch from acute to chronic pain. Cell Reports Medicine. 4(11). 101265–101265. 17 indexed citations
11.
Pouwels, Petra J. W., Nicole I. Wolf, Holger Rehmann, et al.. (2023). A second case of glutaminase hyperactivity: Expanding the phenotype with epilepsy. JIMD Reports. 64(3). 217–222. 3 indexed citations
12.
Gerrits, Johan, et al.. (2023). Metabolic Alterations in NADSYN1-Deficient Cells. Metabolites. 13(12). 1196–1196. 3 indexed citations
13.
Boks, Marco P., Ania Fiksinski, Jacob Vorstman, et al.. (2022). Untargeted metabolic analysis in dried blood spots reveals metabolic signature in 22q11.2 deletion syndrome. Translational Psychiatry. 12(1). 97–97. 5 indexed citations
14.
Schene, Imre F., Arif Ibrahim Ardisasmita, Nalan Liv, et al.. (2021). The potential and limitations of intrahepatic cholangiocyte organoids to study inborn errors of metabolism. Journal of Inherited Metabolic Disease. 45(2). 353–365. 8 indexed citations
15.
Magnúsdóttir, Stefanía, Mia L. Pras‐Raves, Judith Jans, et al.. (2020). MetaboShiny: interactive analysis and metabolite annotation of mass spectrometry-based metabolomics data. Metabolomics. 16(9). 99–99. 16 indexed citations
16.
Shamseldin, Hanan E., Amal Alhashem, Mais Hashem, et al.. (2019). MDH1 deficiency is a metabolic disorder of the malate–aspartate shuttle associated with early onset severe encephalopathy. Human Genetics. 138(11-12). 1247–1257. 40 indexed citations
17.
Ramos, Rúben J., Monique Albersen, Esmee Vringer, et al.. (2019). Discovery of pyridoxal reductase activity as part of human vitamin B6 metabolism. Biochimica et Biophysica Acta (BBA) - General Subjects. 1863(6). 1088–1097. 23 indexed citations
18.
Maier, Oliver, Holger Rehmann, Maarten H. Lequin, et al.. (2018). Identification of a Loss-of-Function Mutation in the Context of Glutaminase Deficiency and Neonatal Epileptic Encephalopathy. JAMA Neurology. 76(3). 342–342. 34 indexed citations
19.
Velden, Monique G.M. de Sain–van der, Maria van der Ham, Johan Gerrits, et al.. (2017). Quantification of metabolites in dried blood spots by direct infusion high resolution mass spectrometry. Analytica Chimica Acta. 979. 45–50. 32 indexed citations
20.
Velden, Monique G.M. de Sain–van der, Maria van der Ham, Judith Jans, et al.. (2016). A New Approach for Fast Metabolic Diagnostics in CMAMMA. JIMD Reports. 30. 15–22. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026